Articles

Poll

Podcasts

Slideshows

Videos

This FDA News Month in Review provides a round-up of regulatory decisions from April 2025.


FDA News Recap: April 2025

The month in review spotlights renal FDA news and novel research about CKD and social determinants of health in kidney care.

Nephrology Month in Review: April 2025

From 1990-2021, global CKD-related deaths and DALYs attributable to physical inactivity increased, especially in low-SDI regions and among females.

Study Highlights Growing Burden of CKD Attributable to Low Physical Activity

Norouzi discusses recent advancements in IgAN therapeutics and looks ahead to a potential first FDA-approved FSGS treatment.

The Evolving IgAN Treatment Landscape and Advances in FSGS, with Sayna Norouzi, MD

Norouzi reflects on significant advances in glomerular disease from Q1 and looks ahead to what the rest of 2025 may have to offer.

What’s New and What’s Next in Glomerular Disease Care, with Sayna Norouzi, MD

Prophylactic treatment with IV magnesium led to a lower risk of cisplatin-associated AKI in patients with cancer undergoing cisplatin chemotherapy.

Prophylactic IV Magnesium Linked to Lower Cisplatin-Associated AKI Risk

Several mobile apps effectively improved medication adherence in patients with CKD, posing important implications for their impact on clinical outcomes.

Mobile Apps Show Promise for Improving CKD Medication Adherence

Kraus explains current unmet needs in IgA nephropathy and what sibeprenlimab may offer based on the phase 3 VISIONARY study.

Sibeprenlimab’s Potential in IgA Nephropathy, with John Kraus, MD, PhD

Tumlin reviews findings from a posthoc analysis of DUPLEX demonstrating sparsentan’s impact on partial remission, complete remission, and kidney failure.

Sparsentan and Progression to Kidney Failure in FSGS, with James Tumlin, MD

Black patients disproportionately started dialysis at low-quality facilities and were less likely to have nephrologists with high-quality primary facilities.

Study Suggests Racial Disparities in Access to High-Quality Dialysis Facilities

C3 Glomerulopathy

The HCPLive C3 glomerulopathy page is a resource for medical news and expert insights on C3G. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in C3G, and more.

IgA Nephropathy

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.

Focal Segmental Glomerulosclerosis

The HCPLive focal segmental glomerulosclerosis page is a resource for medical news and expert insights on FSGS. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in FSGS, and more. 

Chronic Kidney Disease

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.